Healthy volunteers test psilocybin combo for future therapies
NCT ID NCT07079930
First seen Feb 05, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This early-stage study tests the safety and psychological effects of combining psilocybin (a psychedelic compound) with D-serine in 10 healthy adults aged 25-60. Participants receive one of two dose levels to see if D-serine can reduce the psychedelic experience. The goal is to gather safety data for a future Phase 2 trial, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hadassah Medical Organization, Jerusalem, Israel
RECRUITINGJerusalem, Israel
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.